| Date Filed | Type | Description |
| 07/05/2023 |
4
| Allen Andrew R (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 73,212 options to buy
@ $0
Granted 56,868 options to buy
@ $0
Granted 45,348 options to buy
@ $0
Granted 109,746 options to buy
@ $0
Granted 152,376 options to buy
@ $0 |
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2023 |
3
| Allen Andrew R (Director) has filed a Form 3 on Adaptimmune Therapeutics PLC |
| 06/01/2023 |
4
| Allen Andrew R (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Disposed/sold 16,800 options to buy
@ $0.97, valued at
$16.3k
Disposed/sold 12,100 options to buy
@ $5.21, valued at
$63k
Disposed/sold 12,100 options to buy
@ $31.83, valued at
$385.1k
Disposed/sold 5,000 options to buy
@ $16.1, valued at
$80.5k
Disposed/sold 6,270 options to buy
@ $16.11, valued at
$101k
Disposed/sold 8,072 options to buy
@ $6.07, valued at
$49k
|
|
| 02/06/2023 |
4
| Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 738,550 shares
@ $0 |
|
| 12/19/2022 |
4
| Allen Andrew R (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 16,800 options to buy
@ $0.97, valued at
$16.3k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2022 |
4
| Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 70,000 shares
@ $0
Granted 410,000 options to buy
@ $5.46, valued at
$2.2M
|
|
| 12/10/2021 |
4
| Allen Andrew R (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 12,100 options to buy
@ $5.21, valued at
$63k
|
|
| 11/19/2021 |
4
| Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 48,200 shares
@ $0 |
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2021 |
4
| Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 290,000 options to buy
@ $13.87, valued at
$4M
|
|
| 12/11/2020 |
4
| Allen Andrew R (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 12,100 options to buy
@ $31.83, valued at
$385.1k
|
|
| 06/10/2020 |
4
| Allen Andrew R (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 12,030 options to buy
@ $13.98, valued at
$168.2k
|
|
| 06/02/2020 |
4
| Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 14,013 options to buy
@ $17.55, valued at
$245.9k
|
|
| 03/18/2020 |
4
| Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Exercised 12,500 options to buy
@ $9.33, valued at
$116.6k
|
|
| 12/20/2019 |
4
| Allen Andrew R (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 5,000 options to buy
@ $16.1, valued at
$80.5k
|
|
| 06/12/2019 |
4
| Allen Andrew R (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.66, valued at
$19.8k
|
|
| 06/07/2019 |
4
| Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 17,633 options to buy
@ $13.74, valued at
$242.3k
|
|
| 04/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2019 |
4
| Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 180,000 options to buy
@ $12.02, valued at
$2.2M
|
|
| 02/13/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/11/2018 |
4
| Allen Andrew R (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Bought 66,000 shares
@ $1.64, valued at
$108.2k
|
|
| 09/27/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/14/2018 |
4
| Allen Andrew R (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.27, valued at
$81.8k
|
|
| 05/31/2018 |
4
| Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 12,500 options to buy
@ $17, valued at
$212.5k
|
|
| 11/13/2017 |
4
| Allen Andrew R (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.92, valued at
$96k
|
|
| 10/25/2017 |
3
| Allen Andrew R (Director) has filed a Form 3 on Sierra Oncology, Inc. |
| 06/26/2017 |
4
| Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.65, valued at
$170.6k
|
|
| 05/23/2016 |
4
| Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc. |
| 06/07/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/15/2013 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
|